Cargando…
Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children’s Oncology Group phase I consortium study
BACKGROUND: Children with diffuse intrinsic pontine gliomas (DIPG) have a dismal prognosis. Adavosertib (AZD1775) is an orally available, blood-brain barrier penetrant, Wee1 kinase inhibitor. Preclinical efficacy against DIPG is heightened by radiation induced replication stress. METHODS: Using a ro...
Autores principales: | Mueller, Sabine, Cooney, Tabitha, Yang, Xiaodong, Pal, Sharmistha, Ermoian, Ralph, Gajjar, Amar, Liu, Xiaowei, Prem, Komal, Minard, Charles G, Reid, Joel M, Nelson, Marvin, Haas-Kogan, Daphne, Fox, Elizabeth, Weigel, Brenda J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209747/ https://www.ncbi.nlm.nih.gov/pubmed/35733515 http://dx.doi.org/10.1093/noajnl/vdac073 |
Ejemplares similares
-
DIPG-01. REIRRADIATION PRACTICES FOR DIFFUSE INTRINSIC PONTINE GLIOMA
por: Cacciotti, Chantel, et al.
Publicado: (2020) -
Effect of food on the pharmacokinetics of the WEE1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors
por: Någård, Mats, et al.
Publicado: (2020) -
Targeted inhibition of the methyltransferase SETD8 synergizes with the Wee1 inhibitor adavosertib in restraining glioblastoma growth
por: Della Monica, Rosa, et al.
Publicado: (2023) -
A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors
por: Falchook, Gerald S, et al.
Publicado: (2023) -
Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status
por: Roering, Pia, et al.
Publicado: (2022)